Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: Long-term results of the UNICANCER ACCORD 16 phase II trial

Levy, A., Azria, D., Pignon, J. P., Delarochefordiere, A., Martel-Lafay, I., Rio, E., … Deutsch, E. (2015, March 1). Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: Long-term results of the UNICANCER ACCORD 16 phase II trial. Radiotherapy and Oncology. Elsevier Ireland Ltd. https://doi.org/10.1016/j.radonc.2015.02.008